Denali Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $477k | 19k | 25.72 |
| 2022-12-31 | $1.7M | 61k | 27.81 |
| 2022-09-30 | $3.5M | 113k | 30.69 |
| 2021-06-30 | $1.6M | 20k | 78.43 |
| 2021-03-31 | $2.2M | 38k | 57.09 |
| 2020-12-31 | $1.6M | 20k | 83.75 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management